RxDoctor Payments Data

Matthew Johnson, MD

Vascular & Interventional Radiology · Indianapolis, INNPI 1588607451

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $60,191 of the $92,378 with a category attached, or 65.2%. 17 manufacturers reported payments, led by Boston Scientific at 48.4% of the total. Reporting peaked in 2019 at $24,510 and has fallen 56.6% since, to $10,641 in 2025.

$92,378in general payments, 2019–2025

Across 114 payments — averaging $810.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$45K
  • Argon Medical Devices, Inc.$17K
  • Varian Medical Systems, Inc.$14K
  • Biocompatibles, Inc.$8K
  • E.r. Squibb & Sons, L.L.C.$4K
  • F. Hoffmann-la Roche AG$2K
  • plus $2K from 11 others
$80,407in research payments, 2019–2025

Across 12 payments — averaging $6700.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Instylla, Inc.$69K
  • Boston Scientific$9K
  • Biocompatibles UK Ltd$2K

What the payments were for

  • Consulting fees$60,19165%
  • Speaking & faculty fees$18,19520%
  • Travel & lodging$8,6199%
  • Food & beverage$5,3736%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$92,378 in reported general payments places this provider in the 85th percentile of 74 vascular & interventional radiology providers in Indiana.

See all vascular & interventional radiology providers in Indiana

Medicare billing

Part B allowed, 2024
$32,635
Medicare patients
398
Services billed
649

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →